Adults with cystic fibrosis (CF) are less active than they should be, although they have comparable activity levels to…
Catarina Silva, MSc
With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Catarina Silva, MSc
More than 60 cystic fibrosis experts strongly support Relizorb being made available to CF patients on tube feeding, pushing in…
Vertex Pharmaceuticals and Arbor Biotechnologies have established a partnership to discover new proteins to advance the development of…
Prepubescent children with cystic fibrosis (CF) have lower bone density compared to healthy children, and findings are comparable using two…
Synthetic Peptide Might Be Potential Treatment for Bacterial Infection Often Seen in CF Patients
Pseudomonas aeruginosa is a bacteria that commonly infects cystic fibrosis patients. Now, researchers have designed a synthetic peptide that blocks…
Synspira has started a Phase 1a clinical trial to determine the safety and tolerability of its cystic fibrosis therapy candidate…
Preclinical data shows that AB-PA01 can reduce biofilms produced by the bacteria Pseudomonas aeruginosa, a major cause of lung infections in…